Results Of The Initial Offer For Participatory Interest In The Sygnia Itrix Solactive Healthcare 150 ETF - SYGH The Sygnia Itrix Collective Investment Scheme in Securities Sygnia Itrix Solactive Healthcare 150 ETF JSE code: SYGH Short name: SYGDMH150 ISIN code: ZAE000300521 (“SYGH”) A portfolio in the Sygnia Itrix Collective Investment Scheme in Securities, registered as such in terms of the Collective Investment Schemes Control Act, 45 of 2002. Publication of results of the Initial Offer for Participatory Interests in the Sygnia Itrix Solactive Healthcare 150 ETF 1. Results of the Initial Offer Further to the announcement released on SENS on 22 July 2021 regarding the listing approval of Sygnia Itrix Solactive Healthcare 150 ETF Participatory Interests (“Participatory Interests”) and the timetable applicable for the initial offer ("Offer") of the Participatory Interests, and using the definitions in such announcement unless otherwise indicated, the Manager hereby announces the results of the Offer. The total subscription that was received in respect of the Offer amounts to R125 040 000.00 • Investors who undertook in-specie subscriptions ("In-Specie Investors")subscribed for R0.00 worth of Participatory Interests. • Investors who undertook cash subscriptions ("Cash Investors") subscribed for R125 040 000.00 worth of Participatory Interests. 2. Issue of letters of allotment (Cash Investors) One letter of allotment ("LA") will be issued for every Rand subscribed to the subscriber's CSDP or broker account on 28 July 2021, and the corresponding Rand amount debited to the broker or CSDP account on 28 July 2021. The conversion ratio in respect of the number of Participatory Interests issued against each LA will be published on 04 August 2021. The ratio of the participatory interest will be determined after the closing ramp-up period as set out in the Supplement. 28 July 2021 Sponsor Vunani Date: 28-07-2021 08:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.